Alkermes (United States)

Alkermes (United States)

Alkermes plc is a fully-integrated biopharmaceutical company that focuses on developing medicines for psychiatric and neurological disorders. The company was founded in 1987 by Michael Wall. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Alkermes (United States), United States, covering academic research published from 2000 to 2024. Read More.


Open Access Percentage

49%


Total
Publications

482


Total Open
Publications

234


Total
Citations

14K


Open Access
Percentage

49%


Total
Publications

482


Total Open
Publications

234


Total
Citations

14K

Wikipedia

Website

download

Breakdown

23% 20% 5% 52%

Publisher Open

23%

Both

20%

Other Platform Open

5%

Closed

52%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

051015202530354045505560Total Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

28%OA Journal

OA Journal 28%

59

Hybrid 37%

77

No Guarantees 35%

72

Other Platform Open

Domain 78%

95

Other Internet 20%

24

Institution 13%

16

Preprint 2%

2

Public 1%

1

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
94
DOI
Other Internet
23
Europe PMC
Domain
6
King's College London
Institution
4
Washington University in St. Louis
Institution
2
Unknown Repository
Other Internet
2
University of Limerick
Institution
2
iu.edu OAI-PMH Repository
Institution
2
bioRxiv
Preprint
2
University of St Andrews
Institution
1
1 / 2

Data updated 18 August 2025

Share

Share

Share